Video

Evaluation of Executive Dysfunction - Assessing Cognitive Impairment

Brief Evaluation of Executive Dysfunction: An Essential Refinement in the Assessment of Cognitive Impairment

By: Gary J. Kennedy, MD, and Suhey Franco Cadet, MD, Division of Geriatric Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center

WHY: In the familiar environment and daily routine of the older adult’s home life, slowly progressive subtle cognitive changes may not be apparent. Such changes, however, often become obvious in the disorienting setting of the hospital provoking family to report “my mother was never like this at home.” Even when delirium has cleared with resolution of the acute event, unrecognized cognitive impairment can jeopardize safe return to the community.

This Try This:® recommends assessing executive function for older patients not thought to have dementia prior to hospitalization but where the patient, family or staff feel the patient has not returned to baseline cognitive status at the time of discharge. Particularly when the older patient is alert, and verbal and memory is not obviously impaired, screening for executive dysfunction can be critical to a safe, realistic treatment and discharge plan. Patients who exhibit executive dysfunction should be referred to their primary care provider, or to a provider with expertise in dementia assessment. And data suggest that if memory and learning are intact, executive dysfunction can be ameliorated by training the person to anticipate and compensate for the deficits.

Executive dysfunction defined: Executive function is an interrelated set of abilities that includes cognitive flexibility, concept formation, problem solving, and self-monitoring. Assessing executive function can help determine a patient’s capacity to execute health care decisions and discharge plans. With impaired executive dysfunction, instrumental activities of daily living (accounting, shopping, medication management, driving) may be beyond the person’s capacity even though memory impairment is mild. The person’s capacity to exercise command of the environment and self-control, and to direct others to provide care, becomes diminished. Executive dysfunction is one of the neurocognitive domains in the DSM-5 criteria for the diagnosis of dementia and occurs in all dementing diseases. Progressive, disabling executive function even in the absence of memory impairment may be sufficient for the diagnosis.

NOTE: Patients with impaired executive function need not have impaired memory.

BEST PRACTICES: Few practitioners are familiar with testing for executive function, yet there are brief valid and reliable instruments. The instruments listed below have good internal consistency, inter-rater reliability and are strongly correlated with Folstein’s Mini-Mental Status Exam (MMSE) and with lengthier neuropsychological assessments of executive function:

• Royall’s CLOX (clock drawing)
• Controlled Oral Word Association Test
• Trail Making Test, oral version

TARGET POPULATION: Older patients:
• Not thought to have dementia prior to hospitalization but where the patient, family or staff feel the patient has not returned to baseline cognitive status at the time of discharge.
• For whom other screening instruments (e.g., Try This:® MoCA, Mini-Cog, CAM) reveals minimal or no cognitive impairment.
• For whom cognitive impairment, observed as alterations in memory, use of language and abstract thinking, and manipulation of objects in space persists even when delirium has been identified and treated or ruled out.

VALIDITY AND RELIABILITY: Studies of executive dysfunction suggest that its presence predicts level of care among community residents making the transition to less independent living. And among older adults without dementia who have recovered from a major depressive episode, the presence of executive dysfunction is associated with excess, persistent disability and poorer response to antidepressant medication. 

STRENGTHS AND LIMITATIONS: The accurate characterization of executive dysfunction is confounded by language, education, and time of assessment. If the patient and examiner do not share a common mother tongue, the Controlled Oral Word Association and the oral version of the Trail Making tests become too difficult. Persons who are educationally disadvantaged may also perform in the impaired range but not be genuinely dysfunctional. Over the course of hospitalization executive dysfunction often improves but may persist at reduced but disabling levels. When executive dysfunction occurs in depression, problem solving psychotherapy may lessen the disability.

MORE ON THE TOPIC:

Best practice information on care of older adults: www.ConsultGeri.org.

Buslovich, S., & Kennedy, G.J. (2012). Prevalence and Potential Impact of Screening for Subtle Cognitive Deficits on Hospital Readmissions. Journal of the American Geriatrics Society, 60(10), 1980-1981.

Cantor, J., Ashman, T., Dams-O’Connor, K., Dijkers, M.P., Gordon, W., Spielman, L., Tsaousides, T., Allen, H., Nguyen, M., & Oswald, J. (2014). Evaluation of the short-term executive plus intervention for executive dysfunction after traumatic brain injury: A randomized controlled trial with minimization. Archives of Physical Medicine and Rehabilitation, 95, 1-9.

Chan, E., MacPherson, S.E., Robinson, G., Turner, M., Lecce, F., Shallice, T., & Cipolotti, L. (2015). Limitations of the trail making test part-B in assessing frontal executive dysfunction. Journal of the International Neuropsychological Society, 21(2), 169-174. doi: 10.1017/S135561771500003X.

Ilieva, I.P., Alexopoulos, G.S., Dubin, M.J., Morimoto, S.S., Victoria, L.W., & Gunning, F.M. (In press, 2017). Age-related repetitive transcranial magnetic stimulation effects on executive function in depression: A systematic review. American Journal of Geriatric Psychiatry. doi: 10.1016/j.jagp.2017.09.002.

Kuzmickienė, J., & Kaubrys, G. (2016). Specific features of executive dysfunction in Alzheimer-type mild dementia based on computerized Cambridge Neuropsychological Test Automated Battery (CANTAB) test results. Medical Science Monitor, International Medical Journal of Experimental and Clinical Research, 22, 3605-3613.

Moreira, H.S., Costa, A.S., Castro, S.L., Lima, C.F., & Vicente, S.G. (2017). Assessing executive dysfunction in neurodegenerative disorders: A critical review of brief neuropsychological tools. Frontiers in Aging Neuroscience, 9, Article 369. doi: 10.3389/fnagi.2017.00369.

Pimontel, M.A., Rindskopf, D., Rutherford, B.R., Brown, P.J., Roose, S.P., & Sneed, J.R. (2016). A meta-analysis of executive dysfunction and antidepressant treatment response in late-life depression. American Journal of Geriatric Psychiatry, 24(1), 31-41.

van Rooij, F.G., Plaizier, N.O., Vermeer, S.E., Góraj, B.M., Koudstaal, P.J., Richard, E., de Leeuw, F.E., Kessels, R.P.C., & van Dijk, E.J. (2017). Executive function declines in the first 6 months after a transient ischemic attack or transient neurological attack. Stroke, 48(12), 3323-3328. doi:10.1161/STROKEAHA.117.018298.

Ricker, J.H., & Axelrod, B.N. (1994). Analysis of an oral paradigm for the trail making test. Assessment, 1(1), 47-51.

Royall, D.R., Cordes, J.A., & Polk, M. (1998). CLOX: An executive clock drawing task. Journal of Neurology, Neurosurgery, and Psychiatry, 64(5), 588-594.

Spreen, F.O., & Benton, A.L. (1977). Manual of instructions for the Neurosensory Center Comprehensive Examination for Aphasia. Victoria, British Columbia, Canada: University of Victoria.